ICRM
BEAT

Insight Capital Research & Management’s BioTelemetry, Inc. BEAT Stock Holding History

Insight Capital Research & Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-39,138
Closed -$1.31M – 153
2017
Q2 		$1.31M Buy
+39,138
New +$1.17M 0.77% 58
2016
Q4 		– Sell
-138,203
Closed -$2.57M – 152
2016
Q3 		$2.57M Buy
+138,203
New +$2.61M 1.14% 39

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Insight Capital Research & Management's BEAT Position: Q3 2017 in Review

Insight Capital Research & Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 39,138 shares — an estimated $1.31M sold.

Insight Capital Research & Management first reported a position in BEAT in Q3 2016 and held it in 2 quarters. The position peaked at $2.57M in Q3 2016. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

  • Insight Capital Research & Management reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
  • Insight Capital Research & Management sold 39,138 BioTelemetry, Inc. shares in Q3 2017, an estimated $1.31M.
  • Insight Capital Research & Management first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 2 quarters.
  • Insight Capital Research & Management's BioTelemetry, Inc. position peaked at $2.57M in Q3 2016.
  • 211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.